(THIS ARTICLE IS COURTESY OF GLOBAL VOICES)
The U.S. Food and Drug Administration (FDA) recently granted orphan drug approvalfor Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr. Henry Lowe.
Dr. Lowe founded Medicanja Ltd — described as “Jamaica’s first medical cannabis company” — in 2013. Its distinguished board of directors includes two former prime ministers and a former governor general.
The US Orphan Drug Act gives special status to a drug or biological product to treat a rare disease or condition upon the request of a sponsor. Under the act, Dr Lowe will qualify for some development incentives, including tax credits for some clinical testing.
View original post 1,047 more words